Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Sr. V.P., Regulatory Affairs
-
Stock Symbol
-
SUPN on Nasdaq
Tami Tillotson Martin - trading volume in the past year for Supernus Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
86.9K |
$2.53M |
$29.06 |
Feb 23, 2024 |
Direct |
|
|
| Restricted Stock Unit |
3.75K |
$105K |
$27.94 |
Feb 23, 2024 |
Direct |
Common Stock |
|
| Employee Stock Option (Right to Buy) |
0 |
|
|
Jan 10, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.